#apaperaday
#apaperaday will be back tomorrow. Due to the @microsoft.com outage and travel hassle coming back from the PPMD dystrophin meeting, there are some deadlines that I can only now start working on. A picture of Klaus and one of Yuzu to soften the blow.
November 16, 2026 at 7:53 AM
#apaperaday Today’s final PPMD dystrophin meeting focused pick is by Garcia-Uzquiano et al in Frontiers in Medicine on the willingness of health care professionals to adapt Duchenne gene therapy. DOI 10.3389/fmed.2026.1985172
November 13, 2026 at 11:40 AM
#apaperaday Another PPMD dystrophin meeting themed special by Mendell et al in Neurology Therapy on the 3 year follow up of the Duchenne patients treated at the start of the EMBARK study with elevidys. Doi 0.1007/s40120-026-01059-y
November 12, 2026 at 10:13 AM
#apaperaday Today's pick is Duchenne and dystrophin themed to commemorate the PPMD meeting on dystrophin taking place tomorrow (traveling today). The pick is by Pien et al in @jci.org on AAV mediated delivery of a base editor in a Duchenne mouse model. doi: 10.1172/JCI202378
November 11, 2026 at 7:12 AM
#apaperaday Today's pick is from @journalnd.bsky.social by Haynie et al on a survey with USA caregivers of dystrophinopathy patients about their perception of multidisciplinary clinic visits. doi: 10.1177/22143602261502976
November 10, 2026 at 7:22 AM
#apaperaday Today's pick is by Le et al on assessing urinary titin fragments for Becker muscular dystrophy (BMD) patients published in proteomics. Authors use different methods to come to the same conclusion. doi: 10.3390/proteomes14030043
November 9, 2026 at 7:56 AM
#apaperaday Another paper on adrenal insufficiency, today with a pick from @frontiersin.bsky.social Neurology by Sbrocchi et al on the updated PJ Nicholoff steroid protocol. The OPTIMIZE consortium was part of this effort. doi: 10.3389/fneur.2026.1926817
November 6, 2026 at 7:22 AM
#apaperaday We skipped a day as yesterday I was at NWO for a review panel the whole day. Today’s pick is from Molecular Genetics and Metabolism Reports by Montero-Yeboles et al on a Duchenne boy with severe fat embolism syndrome (FES) after a minor trauma. DOI 10.1016/j.ymgmr.2026.101361.
November 5, 2026 at 7:44 AM
#apaperaday Today's pick is by Wang et al in OTS journal Nucleic Acid Therapeutics on how RNA quantification methods can cause artefacts due to RNase H inducing ASO interference. doi: 10.1177/21593337261497131
November 3, 2026 at 7:13 AM
#apaperaday Today's pick is a call for a roadmap to support the development of advanced medicinal productis (ATMPs) in Europe by Eldere et al in Lancet Regional Health Europe. 10.1016/j.lanepe.2026.101688
November 2, 2026 at 7:21 AM
#apaperaday Today's @duchennenl.bsky.social special is a pick by Harris et al from @frontiersmedia.bsky.social molecular medicine on the systemic response of the 4 Duchenne patients receiving the first treatment with Elevidys. 10.3389/fmmed.2026.1953867
October 31, 2026 at 7:35 AM
#apaperaday Today's pick is Duchenne themed to commemorate @duchennenl.bsky.social meeting taking place tomorrow (with a Saturday #apaperaday special). The pick is by Weber et al from @journalnd.bsky.social a guidance document to manage adrenal suppression in Duchenne. doi: 10.1210/jendso/bvaf181
October 30, 2026 at 7:48 AM
#apaperaday Today's pick is a patient organisation perspective on the development of givinostat for Duchenne muscular dystrophy by Buccella and Furlong published in @worldmusclesociety.org journal neuromuscular disorders. Doi 10.1016/j.nmd.2026.107451
October 29, 2026 at 10:36 AM
#apaperaday Today's pick is the paper by Li et al that just appeared in Cell @cellpress.bsky.social on the development and testing of a gene editing therapy for Duchenne muscular dystrophy that sadly was fatal in one of the patients treated. doi: 10.1016/j.cell.2026.09.059
October 28, 2026 at 8:35 AM
#apaperaday Yuzu is back and still knows how to show appreciation for papers. Todays pick is from @journalnd.bsky.social by Rutter et al, and updated guidance on managing growth and puberty concerns in Duchenne patients. Doi 10.1177/22143602261486896
October 27, 2026 at 8:34 AM
#apaperaday We are back in office! Today's pick is by Qin et al in Human Mutation on the discovery of a complex rearrangement in the dystrophin gene causing Duchenne muscular dystrophy. Discovery of the variant allowed the mother to have another, unaffected child.
DOI: 10.1155/humu/8333541
October 26, 2026 at 8:56 AM
#apaperaday @erdera special part 4 is another @mdpiopenaccess.bsky.social paper, by Taran et al in Pharmaceutics on the characterization of a generic nusinersen version, where authors compared it with commercial batches. Doi doi: 10.3390/pharmaceutics18020178
October 23, 2026 at 7:54 AM
#apaperaday @erdera.bsky.social special part 3 is a paper by Chabbi et al in the @mdpiopenaccess.bsky.social journal muscles, a review paper on dystrophin related syndromes: Duchenne, Becker and Carriers (authors mean to say female dystrophinopathy patients). Doi 10.3390/muscles5030060
October 22, 2026 at 7:43 AM
#apaperaday @erdera.bsky.social GAM special part 2 with a pick from Gentile et al in @narjournal.bsky.social on bivalent siRNA for prion disease, a paper from our keynote speaker Sonia Vallabh so an apt pick if I may say so. doi: 10.1093/nar/gkag287.
October 21, 2026 at 9:14 AM
#apaperaday Today's @erdera.bsky.social general assembly meeting (GAM) special is just out in @thelancetneuro.bsky.social by Veerapandiyan et al on the clinical trial with delpacibart zotadirsen (del-zota, exon 44 skipper from Avidity) in Duchenne patients. Doi 10.1016/S1474-4422(26)00337-6.
October 20, 2026 at 7:09 AM
Final #OTS2026 #apaperaday is a different type of paper than normal: a perspective on environmental risks of modified oligonucleotide therapies by Hofstetter et al in environmental science and technology
Doi 10.1021/acs.est.6c05885
October 14, 2026 at 1:08 PM
This will require tools to measure oligonucleotides in wastewater and more studies to see how they are broken down.
NB: tomorrow and Friday there won’t be #apaperaday as I’ll be traveling back home. Monday is for now an unknown but Tuesday-Friday will feature an @erdera.bsky.social GAM special
October 14, 2026 at 1:19 PM
#apaperaday #OTS2026 special continues with a pick by Goncalves et al from orphanet journal of rare diseases on testing ASOs for exon skipping for mucolipidosis type II (ML II). Doi 10.1186/s13023-026-04430-2
October 13, 2026 at 1:55 PM
#apaperaday #OTS2026 special with a paper by Islam et al from genes and development on using antisense oligonucleotides (ASO) to modulate oncogenic EZH2 missplicing. Contains a lot of fundamental work as well! Doi10.1101/gad.353628.126.
October 12, 2026 at 2:14 PM
#apaperaday From Denver where today we have N of 1 collaborative ancillary meetings today and tomorrow we have our annual meeting prior to #OTS2026
Today’s pick is by Heinsinger et al in Neurology of Disease on splicing modulation of ataxin 2 as a strategy to treat ALS
Doi 10.1016/j.nbd.2026.107582
October 9, 2026 at 11:12 AM